1. Back to Outputs Catalog

In Situ Global Structural Proteome Analysis Identifies Potential Biomarkers for Parkinson’s Disease

January 9, 2023

Training and Networking Working Group

In Situ Global Structural Proteome Analysis Identifies Potential Biomarkers for Parkinson's Disease

View Article

A hot topic discussing an article by Mackmull and colleagues that investigated the potential of LiP-MS for detecting structural proteome alterations in PD

Training and Networking Working Group

The Training and Networking working group promotes training and networking throughout the GP2 project.
Learn more about Training and Networking Working Group

Meet the authors

Assistant Professor & Researcher

Inas Elsayed

Faculty of pharmacy University of Gezira | Sudan

More outputs and publications

Towards a Global View of Parkinson's Disease Genetics
Description Parkinson\’s disease (PD) is a global health challenge, yet historically studies of PD have taken place predominantly in European populations. Recent genetics research conducted in non-European populations has revealed novel population-specific genetic loci linked to PD risk, highlighting the importance of studying PD globally. These insights have broadened our understanding of PD etiology, which […]
Read More
Mendelian Randomization and Parkinson's Disease
Description Integrative Omics in Parkinson’s Disease provides a comprehensive understanding of the current literature on high-throughput technologies relating to discoveries for Parkinson\’s disease etiology. This emerging field uses large omics datasets to investigate the etiology of Parkinson’s disease and other forms of parkinsonism. The book traces the evolution of omics technologies from the discovery of […]
Read More
Is SH3GL2 p.G276V the Causal Functional Variant Underlying Parkinson's Disease Risk at this Locus?
We read with great interest the article by Bademosi and colleagues, where they investigated the role of SH3GL2 p.G276V on neuron dysfunction in Parkinson's disease (PD).
Read More